EVERGREEN Webinar: Clinical FAQs on T2DM Care, Addressed by Dr V Mohan Dr Jeegar Dattani6 March 2024 12:29 PM ISTThe Evergreen webinar addressed the clinical applicability of Linagliptin and Dapagliflozin in real-world clinical scenarios of type 2 diabetes....
2023 In Review: Major Developments In The Field Of Endocrinology Dr Akhil Krishna26 Dec 2023 11:15 AM IST Let us take a glimpse into the notable progress and accomplishments within the field of endocrinology for the year 2023. This overview showcases...
Top Ten Landmark Trials Across Cardiology - Dr Nihar Mehta Dr Nihar Mehta20 Dec 2023 9:45 AM IST 1. Framingham Heart Study (1948): The inception of modern cardiovascular epidemiology, the Framingham Heart Study, laid the foundation for...
Linagliptin and Dapagliflozin: Therapeutic Applicability in T2DM with High CV Risk Dr. Kamal Kant Kohli13 Dec 2023 11:48 AM ISTType 2 Diabetes Mellitus and Cardiovascular DiseaseType 2 diabetes mellitus (T2DM) prevalence has been increasing globally, particularly in India (1)...
Linagliptin and Dapagliflozin: Evidence for Robust Glycemic Control and Reaping CV-CKD Benefits in T2DM (EVERGREEN) Practice Perspective Dr. Kamal Kant Kohli21 Nov 2023 12:14 PM ISTType 2 diabetes mellitus (T2DM) is growing alarmingly due to rapid urbanization, migration, aging population, and lifestyle changes; with Asia being...
Adverse Effects of Proton Pump Inhibitor Use in Patients with Cardiovascular Disease: Pharmacovigilance Attention Needed!! Dr. Kamal Kant Kohli8 Sept 2023 11:30 AM ISTSince the introduction of proton pump inhibitors (PPIs), they have steadily become the mainstay in treating acid-related disorders. The adoption of...
How to quickly transport organs for transplantation by Air: Dr P.K.Verma Dr. P.K.Verma13 July 2023 9:30 AM ISTOrgan transplantation is a surgical procedure in which tissue or an organ is transferred from one area of a person's body to another area, or from...
Glimepiride Stands Tall on Cardiovascular Safety Again: Latest Update Dr. Prem Aggarwal9 Jun 2023 11:36 AM ISTThe epidemiologic link between diabetes & heart failure is well established, with a burden of heart failure among 22% of patients with diabetes...
Colchicine's beneficial in post AF ablation pericarditis? An elusive question in search of an answer dr. Abhimanyu Uppal27 April 2023 11:00 AM ISTAtrial fibrillation (AF) is the most common sustained cardiac arrhythmia encountered in clinical practice. Catheter ablation is now a well-established...
Torsemide and furosemide show no significant difference in all-cause mortality in HF patients: JAMA Dr. Mahalakshmi Sivashankaran28 March 2023 11:00 AM ISTUSA: A recent Clinical Trial called TRANSFORM-HF, published in JAMA, has found that torsemide and furosemide, two commonly used loop diuretics for...
Management of CVD in Indian Settings and Scope of Amlodipine and Atenolol Fixed-Dose Combination-Review Dr. Prem Aggarwal6 March 2023 11:58 AM ISTCardiovascular diseases (CVDs) have become the leading cause of mortality in India. With one-quarter of all deaths being associated with CVDs,...
Amlodipine as First-line Antihypertensive-Review of Indian Evidence Dr. Prem Aggarwal30 Jan 2023 12:00 PM ISTHypertension, often referred to as "the silent killer," is a significant global public health burden due to its risk for myocardial infarction (MI)...
